Philip W. Kantoff
CIK 1866025 · last filed 2026-06-26
Philip W. Kantoff is a corporate insider who has filed 6 SEC Form 4 insider transactions across 2 companies since 2022. The most recent filing, for CNTX, was dated Jun 26, 2026.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
6
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CNTX | Director | — | $0.59 | — | $0 | 5 | 2026-06-26 |
| ESSA Pharma Inc. (EPIX) Delisted | Director | — | $0.20 | — | $0 | 1 | 2024-03-28 |
Recent Filings
6 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-26 | CNTX | Grant (A) | — | $0 | EDGAR |
| 2025-06-12 | CNTX | Grant (A) | — | $0 | EDGAR |
| 2024-06-14 | CNTX | Grant (A) | — | $0 | EDGAR |
| 2024-03-28 | ESSA Pharma Inc. (EPIX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-05-31 | CNTX | Grant (A) | — | $0 | EDGAR |
| 2022-06-03 | CNTX | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.